Table 3.
Individual indicator and composite measures of patient care for selected clinical conditions by general practice for the period 01/04/2010-31/03/2011
| Clinical conditions & Indicators |
Payment |
|
Participating general practices – codes A-I |
Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Points* | Threshold | A | B | C | D | E | F | G | H | I | ||
|
All patients = n |
|
Min-Max |
7613 |
2277 |
2893 |
4567 |
12850 |
10939 |
3507 |
4600 |
7702 |
56948 |
|
CKD n(%) |
|
|
246 (3.2) |
111 (4.9) |
86 (3.0) |
151 (3.3) |
321 (2.5) |
535 (4.9) |
97 (2.8) |
172 (3.7) |
194 (2.5) |
1913 (3.4) |
| CKD3 |
11 |
40-70% |
186 (75.2) |
72 (64.9) |
64 (74.4) |
116 (76.8) |
255 (79.4) |
421 (78.7) |
85 (87.6) |
85 (87.6) |
143 (73.7) |
1472 (76.9) |
| CKD5 |
9 |
40-80% |
245 (99.6) |
110 (99.1) |
86 (100) |
151 (100) |
316 (98.4) |
532 (99.4) |
96 (99.0) |
96 (99.0) |
192 (99.0) |
1890 (98.8) |
| CKD6 |
6 |
40-80% |
211 (85.8) |
111 (100) |
85 (98.8) |
136 (90.1) |
282 (87.9) |
469 (87.7) |
90 (92.8) |
90 (92.8) |
171 (88.1) |
1707 (89.2) |
|
Overall |
|
|
158 (64.2) |
71 (64.0) |
64 (74.4) |
105 (69.5) |
225 (70.1) |
380 (71.0) |
79 (81.4) |
79 (81.4) |
129 (66.5) |
1320 (69.0) |
|
STROKE/TIA n(%) |
|
|
173 (2.3) |
62 (2.7) |
75 (2.6) |
100 (2.2) |
309 (2.4) |
248 (2.3) |
67 (1.9) |
112 (2.4) |
129 (1.7) |
1275 (2.2) |
| STR6 |
5 |
40-70% |
165 (95.4) |
52 (83.9) |
67 (89.3) |
90 (90.0) |
288 (93.2) |
226 (91.1) |
56 (83.6) |
105 (93.8) |
118 (91.5) |
1167 (91.5) |
| STR8 |
5 |
40-60% |
158 (91.3) |
48 (77.4) |
60 (80.0) |
81 (81.0) |
283 (91.6) |
213 (85.9) |
58 (86.6) |
95 (84.8) |
110 (85.3) |
1106 (86.7) |
| STR12 |
4 |
40-90% |
166 (96.0) |
60 (96.8) |
72 (96.0) |
96 (96.0) |
305 (98.7) |
235 (94.8) |
65 (97.0) |
108 (96.4) |
125 (96.9) |
1232 (96.6) |
| STR10 |
2 |
40-85% |
151 (87.3) |
59 (95.2) |
73 (97.3) |
96 (96.0) |
293 (94.8) |
234 (94.4) |
61 (91.0) |
104 (92.9) |
124 (96.1) |
1195 (93.7) |
|
Overall |
|
|
129 (74.6) |
32 (51.6) |
52 (69.3) |
66 (66.6) |
256 (82.8) |
179 (72.2) |
43 (64.2) |
84 (75.0) |
96 (74.4) |
945 (74.1) |
|
Diabetes Mellitus n(%) |
|
275 (3.6) |
120 (5.3) |
159 (5.5) |
156 (3.4) |
520 (4.0) |
458 (4.2) |
163 (4.6) |
181 (3.9) |
366 (4.8) |
2398 (4.2) |
|
| DM2 |
3 |
40-90% |
265 (96.4) |
120 (100) |
159 (100) |
151 (96.8) |
506 (97.3) |
449 (98.0) |
159 (97.5) |
175 (96.7) |
356 (97.3) |
2340 (97.6) |
| DM24 |
8 |
40-70% |
250 (90.9) |
95 (79.2) |
140 (88.1) |
133 (85.3) |
432 (83.1) |
359 (78.4) |
136 (83.4) |
148 (81.8) |
296 (80.9) |
1989 (82.9) |
| DM9 |
3 |
40-90% |
244 (88.7) |
119 (99.2) |
147 (92.5) |
151 (96.8) |
475 (91.3) |
421 (91.9) |
159 (97.5) |
165 (91.2) |
353 (96.4) |
2234 (93.2) |
| DM10 |
3 |
40-90% |
244 (88.7) |
119 (99.2) |
147 (92.5) |
150 (96.2) |
475 (91.3) |
422 (92.1) |
159 (97.5) |
166 (91.7) |
351 (95.9) |
2233 (93.1) |
| DM12 |
18 |
40-60% |
244 (88.7) |
105 (87.5) |
144 (90.6) |
118 (75.6) |
459 (88.3) |
375 (81.9) |
133 (81.6) |
166 (91.7) |
329 (89.9) |
2060 (85.9) |
| DM13 |
3 |
40-90% |
253 (92.0) |
119 (99.2) |
154 (96.9) |
140 (89.7) |
484 (93.1) |
426 (93.0) |
149 (91.4) |
153 (84.5) |
345 (94.3) |
2244 (93.6) |
| DM22 |
3 |
40-90% |
269 (97.8) |
120 (100.) |
157 (98.7) |
151 (96.8) |
506 (97.3) |
442 (96.5) |
160 (98.2) |
174 (96.1) |
361 (98.6) |
2346 (97.8) |
| DM15 |
3 |
40-80% |
267 (97.1) |
116 (96.7) |
156 (98.1) |
156 (100) |
515 (99.0) |
458 (100) |
160 (98.2) |
180 (99.4) |
359 (98.1) |
2363 (98.5) |
| DM17 |
6 |
40-70% |
253 (92.0) |
109 (90.8) |
145 (91.2) |
147 (94.2) |
475 (91.3) |
396 (86.5) |
139 (85.3) |
155 (85.6) |
313 (85.5) |
2132 (88.9) |
| DM18 |
3 |
40-85% |
246 (89.5) |
118 (98.3) |
153 (96.2) |
139 (89.1) |
492 (94.6) |
419 (91.5) |
147 (90.2) |
162 (89.5) |
351 (95.9) |
2227 (92.9) |
|
Overall |
|
|
166 (60.4) |
75 (62.5) |
103 ( 64.8) |
84 (53.8) |
339 (65.2) |
239 (52.2) |
82 (50.3) |
100 (55.2) |
213 (58.2) |
1401 (58.4) |
|
Sec prev. of CHD n(%) |
|
317 (4.2) |
128 (5.6) |
178 (6.2) |
204 (4.5) |
547 (4.3) |
546 (5.0) |
189 (5.4) |
203(4.4) |
327 (4.2) |
2639 (4.6) |
|
| CHD6 |
17 |
40-70% |
300 (94.6) |
118 (92.2) |
162 (91.0) |
174 (85.3) |
524 (95.8) |
495 (90.7) |
166 (87.8) |
187 (92.1) |
312 (95.4) |
2438 (92.4) |
| CHD8 |
17 |
40-70% |
294 (92.7) |
103 (80.5) |
134 (75.3) |
186 (91.2) |
510 (93.2) |
464 (85.0) |
155 (82.0) |
162 (79.8) |
308 (94.2) |
2316 (87.8) |
| CHD9 |
7 |
40-90% |
293 (92.4) |
120 (93.8) |
172 (96.6) |
199 (97.5) |
541 (98.9) |
511 (93.6) |
172 (91.0) |
195 (96.1) |
319 (97.6) |
2522 (95.6) |
| CHD10 |
7 |
40-60% |
295 (93.1) |
91 (71.1) |
125 (70.2) |
184 (90.2) |
504 (92.1) |
402 (73.6) |
131 (69.3) |
149 (73.4) |
300 (91.7) |
2181 (82.6) |
| CHD11 |
7 |
40-80% |
312 (98.4) |
128 (100) |
178 (100) |
202 (99.0) |
540 (98.7) |
539 (98.7) |
187 (98.9) |
202 (99.5) |
325 (99.4) |
2613 (99.0) |
| CHD12 |
7 |
40-90% |
293 (92.4) |
122 (95.3) |
172 (96.6) |
193 (94.6) |
526 (96.2) |
524 (96.0) |
178 (94.2) |
186 (91.6) |
313 (95.7) |
2507 (95.0) |
|
Overall |
|
|
228 (71.9) |
62 (48.4) |
85 (47.8) |
118 (57.8) |
348 (63.6) |
354 (64.8) |
86 (45.5) |
71 (35.0) |
211 (64.5) |
1690 (64.0) |
|
COPD n(%) |
|
|
163 (2.1) |
72 (3.2) |
92 (3.2) |
36 (0.8) |
286 (2.2) |
298 (2.7) |
55 (1.6) |
176 (3.8) |
142 (1.8) |
1320 (2.3) |
| COPD10 |
7 |
40-70% |
152 (93.3) |
69 (95.8) |
85 (92.4) |
32 (88.9) |
254 (88.8) |
273 (91.6) |
52 (94.5) |
167 (94.9) |
74 (52.1) |
1158 (87.7) |
| COPD13 |
9 |
50-90% |
155 (95.1) |
69 (95.8) |
85 (92.4) |
34 (94.4) |
270 (94.4) |
280 (94.0) |
54 (98.2) |
170 (96.6) |
137 (96.5) |
1254 (95.0) |
| COPD8 |
6 |
40-85% |
150 (92.0) |
72 (100) |
88 (95.7) |
35 (97.2) |
270 (94.4) |
278 (93.3) |
53 (96.4) |
166 (94.3) |
134 (94.4) |
1246 (94.4) |
| Overall | 140 (85.9) | 69 (95.8) | 83 (90.2) | 30 (83.3) | 231 (80.8) | 254 (85.2) | 50 (90.9) | 157 (89.2) | 68 (47.9) | 1082 (82.0) | ||
*The number of points per indicator reflects the allocated number available during the study period.